3 years ago
FATE
AnalystsRobert BurnsRobert Burns's Stock Forecasts
AnalystsRobert Burns
Sectors:
Industries:
Analyst Ranking
Bottom 1%
#5013 out of 5014 analysts
Average Return
-12.41%
Win Rate
33%168 out of 513
Risk vs Reward
Poor
Good
Robert Burns's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Tango Therapeutics IncTNGX | +387.31% | $1.34 | $6.53 | 2025-04-13 - 2025-09-12 | Buy |
Immunomedics IncIMMU | +342.36% | $18.91 | $83.65 | 2020-04-06 - 2020-09-14 | Buy |
Adc Therapeutics SaADCT | +287.50% | $0.80 | $3.10 | 2023-09-18 - 2024-09-18 | Buy |
Turning Point Therapeutics IncTPTX | +208.74% | $35.13 | $108.46 | 2020-03-16 - 2021-03-17 | Buy |
Revolution Medicines IncRVMD | +201.93% | $19.65 | $59.33 | 2023-11-13 - 2024-11-12 | Buy |
Robert Burns Analyst Color
Get additional color on Robert Burns's coverage of popular stocks
Robert Burns's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Cullinan Therapeutics IncCGEM | 2 | Buy | $24.00 | +267.53% | Reiterates | a day ago |
IMMIX Biopharma IncIMMX | 9 | Buy | $8.00 | +280.95% | Maintains | a day ago |
Telix Pharmaceuticals LtdTLX | 2 | Buy | $20.00 | +117.16% | Maintains | 3 days ago |
Biontech SeBNTX | 43 | Buy | $136.00 | +40.58% | Reiterates | 5 days ago |
Onkure Therapeutics IncOKUR | 4 | Buy | $34.00 | +1,287.76% | Reiterates | 18 days ago |
Relay Therapeutics IncRLAY | 21 | Buy | $14.00 | +250.88% | Maintains | 18 days ago |
Bicara Therapeutics IncBCAX | 5 | Buy | $40.00 | +244.23% | Maintains | 22 days ago |
Oric Pharmaceuticals IncORIC | 25 | Buy | $19.00 | +76.25% | Maintains | a month ago |
Arrivent Biopharma IncAVBP | 11 | Buy | $42.00 | +113.09% | Maintains | a month ago |
Exelixis IncEXEL | 10 | Buy | $46.00 | +17.50% | Maintains | a month ago |
Black Diamond Therapeutics IncBDTX | 14 | Buy | $10.00 | +207.69% | Maintains | a month ago |
Y Mabs Therapeutics IncYMAB | 15 | Hold | $8.60 | +0.12% | Downgrades | a month ago |
Cogent Biosciences IncCOGT | 12 | Buy | $21.00 | +65.88% | Maintains | a month ago |
Cardiff Oncology IncCRDF | 3 | Buy | $10.00 | +387.80% | Maintains | a month ago |
Adicet Bio IncACET | 1 | Buy | $4.00 | +393.83% | Assumes | 2 months ago |
Elicio Therapeutics IncELTX | 8 | Buy | $13.00 | +13.04% | Maintains | 2 months ago |
Nurix Therapeutics IncNRIX | 16 | Buy | $34.00 | +276.11% | Maintains | 2 months ago |
Karyopharm Therapeutics IncKPTI | 1 | Buy | $27.00 | +318.60% | Assumes | 2 months ago |
Replimune Group IncREPL | 16 | Buy | $22.00 | +283.94% | Reiterates | 2 months ago |
Zymeworks IncZYME | 21 | Hold | $13.00 | -17.41% | Reiterates | 2 months ago |
Enliven Therapeutics IncELVN | 5 | Buy | $48.00 | +140.48% | Maintains | 2 months ago |
Tuhura Biosciences IncHURA | 3 | Buy | $12.00 | +380.00% | Reiterates | 4 months ago |
Revolution Medicines IncRVMD | 18 | Buy | $72.00 | +54.67% | Maintains | 4 months ago |
Prelude Therapeutics IncPRLD | 16 | Buy | $5.00 | +342.48% | Reiterates | 4 months ago |
Springworks Therapeutics IncSWTX | 29 | Hold | $47.00 | +0.02% | Downgrades | 4 months ago |
Caribou Biosciences IncCRBU | 14 | Buy | $3.00 | +66.67% | Maintains | 5 months ago |
Tango Therapeutics IncTNGX | 12 | Buy | $13.00 | +99.08% | Reiterates | 5 months ago |
Adc Therapeutics SaADCT | 18 | Buy | $8.00 | +141.69% | Reiterates | 5 months ago |
Perspective Therapeutics IncCATX | 3 | Buy | $10.00 | +187.36% | Reiterates | 5 months ago |
Macrogenics IncMGNX | 18 | Hold | $2.00 | +25.79% | Maintains | 6 months ago |
Pmv Pharmaceuticals IncPMVP | 11 | Buy | $5.00 | +306.50% | Reiterates | 6 months ago |
Allogene Therapeutics IncALLO | 14 | Buy | $8.00 | +607.96% | Maintains | 6 months ago |
Nuvation Bio IncNUVB | 14 | Buy | $10.00 | +218.47% | Maintains | 6 months ago |
Repare Therapeutics IncRPTX | 18 | Buy | $5.00 | +184.09% | Maintains | 6 months ago |
Cargo Therapeutics IncCRGX | 3 | Buy | $33.00 | +638.26% | Reiterates | 10 months ago |
Igm Biosciences IncIGMS | 13 | Hold | $11.00 | N/A | Maintains | a year ago |
Kronos Bio IncKRON | 10 | Buy | $2.25 | N/A | Reiterates | a year ago |
Omega Therapeutics IncOMGAQ | 9 | Buy | $12.00 | N/A | Reiterates | a year ago |
Apollomics IncAPLM | 5 | Buy | $200.00 | N/A | Maintains | a year ago |
Viracta Therapeutics IncVIRX | 8 | Buy | $4.00 | N/A | Reiterates | a year ago |
Effector Therapeutics IncEFTR | 3 | Buy | $24.00 | N/A | Reiterates | a year ago |
Calidi Biotherapeutics IncCLDI | 2 | Buy | $240.00 | N/A | Maintains | a year ago |
Kineta IncKANT | 4 | Buy | $8.00 | N/A | Reiterates | 2 years ago |
Alphaton Capital CorpATON | 5 | Buy | $120.00 | N/A | Maintains | 2 years ago |
Whitehawk Therapeutics IncWHWK | 9 | Buy | $36.00 | N/A | Maintains | 2 years ago |
Kinnate Biopharma IncKNTE | 6 | Buy | $24.00 | N/A | Reiterates | 2 years ago |
Gt Biopharma IncGTBP | 6 | Buy | $150.00 | N/A | Reiterates | 2 years ago |
Atara Biotherapeutics IncATRA | 8 | Buy | $700.00 | N/A | Maintains | 2 years ago |
Imagenebio IncIMA | 4 | Buy | $264.00 | N/A | Reiterates | 2 years ago |
Fate Therapeutics IncFATE | 6 | Hold | $7.00 | N/A | Downgrades | 3 years ago |
Tcr2 Therapeutics IncTCRR | 4 | Buy | $13.00 | N/A | Maintains | 3 years ago |
Neurogene IncNGNE | 3 | Hold | N/A | N/A | Downgrades | 3 years ago |
Forma Therapeutics Holdings IncFMTX | 2 | Hold | $20.00 | N/A | Downgrades | 3 years ago |
Turning Point Therapeutics IncTPTX | 6 | Hold | $76.00 | N/A | Downgrades | 3 years ago |
Cytomx Therapeutics IncCTMX | 1 | Buy | $11.00 | N/A | Maintains | 4 years ago |
Nucana PLCNCNA | 7 | Buy | $45,000.00 | N/A | Maintains | 4 years ago |
Molecular Partners AgMOLN | 1 | Buy | $25.00 | N/A | Assumes | 4 years ago |
Autolus Therapeutics PLCAUTL | 1 | Buy | $13.00 | N/A | Maintains | 5 years ago |
Immunomedics IncIMMU | 4 | Hold | $88.00 | N/A | Downgrades | 5 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.